Evidence map›Paper›PMID 34617706›Full record

ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2021

Transdisciplinarity in the approach to amyloidosis.

Amalia Ernestina Alfonsín, Sofia Stephanie Escada, Dana Kohan, Melina Paula Valeo Chulvi, María Lourdes Posadas Martínez, María Adela Aguirre, Elsa Mercedes Nucifora

Registry-linked trialAbstract read
In one paragraph

Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01347047 (Institutional Registry of Amyloidosis), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01347047 completednot on this map

Institutional Registry of Amyloidosis (Hospital Italiano de Buenos Aires)

TypeobservationalSponsorHospital Italiano de Buenos AiresRan2011 to 2026Enrolled500ConditionsAmyloidosis
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amalia Ernestina AlfonsínHospital Italiano de Buenos Aires - Imtib. amalia.alfonsin@hospitalitaliano.org.ar.
Sofia Stephanie EscadaHospital Italiano de Buenos Aires.. sofia.escada@hospitalitaliano.org.ar.
Dana KohanHospital Italiano de Buenos Aires. dana.kohan@hiba.org.ar.
Melina Paula Valeo ChulviHospital Italiano de Buenos Aires. melina.valeo@hiba.org.ar.
María Lourdes Posadas MartínezHospital Italiano de Buenos Aires. maria.posadas@hiba.org.ar.
María Adela AguirreImtib y Servicio de Clínica médica del Hospital Italiano de Bs As.. adela.aguirre@hiba.org.ar.
Elsa Mercedes NuciforaHospital Italiano de Buenos Aires.. elsa.nucifora@hiba.org.ar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing complexity in the approach to diseases challenges the development of a new paradigm of care that crosses disciplinary limits, where professionals from different disciplines approach a problem applying their expertise, respecting the knowledge of the other and contributing to the global view of the problem. Amyloidoses are rare diseases. The diagnosis is based on the biopsy of those organs in which amyloid infiltration is suspected. There is an increased risk of bleeding associated with these procedures. Therefore, the availability of obtaining samples from certain sites with less invasive accesses, such as the minor salivary glands (GSM), represent an alternative. Objectives: Describe the experiences of GSM biopsies as a diagnostic tool in the detection of amyloidosis and its intra and postoperative complications. - Estimate the diagnostic performance. The design is a cross-sectional cohort. All patients with a suspected diagnosis of amyloidosis were consecutively included, between August 2018-September 2020. Results: 23 biopsies were performed with minimally invasive procedures. 60.86% were male and the average age was 66 years. The prevalence of amyloidosis was 33%. The sensitivity was 55% and the specificity 100%. One patient had more bleeding than usual during the procedure and none had postoperative complications. Conclusions: GSM biopsy experiences were described as a diagnostic tool for amyloidosis, reporting a slight intraoperative complication and no postoperative complication. The test achieved a sensitivity of 55% and a specificity of 100%.

Indexed as

AmyloidosisHumansamyloidosysbiopsysalivary glands

Identifiers

PMID34617706
PMCPMC8760903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.